Table 1 Clinical characteristics of 97 ICC Patients.
Characteristics | HAIC group (n = 37 ) | CisGem group (n = 60) | P value |
|---|---|---|---|
Age, years, median (range) | 48 (37–72) | 49 (37–73) | 0.507 |
Sex | |||
Male | 24 (64.9%) | 40 (66.7%) | > 0.999 |
Female | 13 (35.1%) | 20 (33.3%) | |
ECOG | |||
0 | 24 (64.9%) | 24 (40%) | 0.022 |
1 | 13 (35.1%) | 36 (60%) | |
Tumor number | |||
Single | 14 (37.8%) | 18 (30%) | 0.506 |
Multiple | 23 (62.2%) | 42 (70%) | |
Largest tumor size, cm | |||
< 5 | 10 (27.0%) | 15 (25%) | 0.816 |
≥ 5 | 27 (73.0%) | 45 (75%) | |
Local lymph node metastasis | |||
Absent | 12 (32.4%) | 16 (26.7%) | 0.636 |
Present | 25 (67.6%) | 24 (73.3%) | |
Liver cirrhosis | |||
Absent | 31 (83.8%) | 48 (80%) | 0.789 |
Present | 6 (16.2%) | 12 (20%) | |
Child-Pugh score | |||
A | 26 (70.3%) | 43 (71.7%) | > 0.999 |
B | 11 (29.7%) | 17 (28.3%) | |
CEA, ng/mL, median (range) | 15.4 (1.1–79.3) | 10.3 (1.2–112.2) | 0.888 |
CA199, U/mL, median (range) | 293 (13–1169) | 254 (23–3244) | 0.492 |
ALT, U/L, median (range) | 36 (24–64) | 34.5 (22–67) | 0.920 |
AST, U/L, median (range) | 37 (22–58) | 35.5 (18–75) | 0.934 |
Albumin, g/L, median (range) | 38 (34–42) | 38.5 (32–43) | 0.760 |
Total Bilirubin, umol/L, median (range) | 20.5 (11.7–42.1) | 16.4 (9.5–41.2) | 0.001 |
Curative resection | 3 (8.1%) | 2 (3.3%) | 0.366 |
